BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Meštrović A, Kumric M, Bozic J. Discontinuation of therapy in inflammatory bowel disease: Current views. World J Clin Cases 2024; 12(10): 1718-1727 [PMID: PMC11036474 DOI: 10.12998/wjcc.v12.i10.1718]
URL: https://www.wjgnet.com/1948-5190/full/v12/i10/1718.htm
Number Citing Articles
1
Kazuo Yashima, Hiroki Kurumi, Naoyuki Yamaguchi, Hajime Isomoto. Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologicsExpert Review of Gastroenterology & Hepatology 2025;  doi: 10.1080/17474124.2025.2469832
2
Ya-Xiong Guo, Xiong Yan, Xu-Chang Liu, Yu-Xiang Liu, Chun Liu. Artificial intelligence-driven strategies for managing renal and urinary complications in inflammatory bowel diseaseWorld Journal of Nephrology 2025; 14(1): 100825 doi: 10.5527/wjn.v14.i1.100825